Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Haematologica

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 9573675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Idarubicin in patients with diffuse large cell lymphomas: a randomized trial comparing VACOP-B (A = doxorubicin) vs VICOP-B (I = idarubicin).

  1997cited by this paper
• Full dose CHOP chemotherapy in elderly patients with non-Hodgkin's lymphoma.

  1995cited by this paper
• The use of chemotherapy as palliative treatment for patients with advanced ovarian cancer.

  1995cited by this paper
• Lymphoma in the older patient.

  1995cited by this paper
• A phase II trial of prednisone, oral etoposide, and novantrone (PEN) as initial treatment of non-Hodgkin's lymphoma in elderly patients.

  1995cited by this paper
• Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.

  1995cited by this paper
• Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.

  1995cited by this paper
• Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?

  1994cited by this paper
• P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL).

  1994cited by this paper
• Full-dose chemotherapy for non-Hodgkin's lymphoma in the elderly. Dutch Hematology-Oncology in Adults Study Group.

  1994cited by this paper
• Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.

  1993cited by this paper
• Non-Hodgkin's lymphomas in elderly patients.

  1993cited by this paper
• P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma.

  1993cited by this paper
• A predictive model for aggressive non-Hodgkin's lymphoma.

  1993cited by this paper
• VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly.

  1993cited by this paper
• In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy.

  1993cited by this paper
• Non-Hodgkin's lymphoma time trends: United States and international data.

  1992cited by this paper
• Chronological age is a multifactorial prognostic variable in patients with non-Hodgkin's lymphoma.

  1992cited by this paper
• A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma.

  1992cited by this paper
• Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma.

  1991cited by this paper
• A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.

  1988cited by this paper
• Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma.

  1987cited by this paper
• Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.

  1986cited by this paper
• Initial chemotherapy with an age-adjusted CHOP-schedule in non-Hodgkin lymphomas with unfavorable prognosis. A study of the I.G.C.I.

  1986cited by this paper
• The importance of dose intensity in chemotherapy of metastatic breast cancer.

  1984cited by this paper
• Report of the Committee on Hodgkin's Disease Staging Classification.

  1971cited by this paper

• Diffuse large B-cell lymphoma in the older.

  2011cites this paper
• randomized trial of PAdriaCEBO versus PMitCEBO patients older than 60 with high-grade lymphoma: results of a BNLI Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for

  2008cites this paper
• Introduction of rituximab in front‐line and salvage therapies has improved outcome of advanced‐stage follicular lymphoma patients

  2007cites this paper
• Long-term Results of a Multicenter Randomized, Comparative Trial of Modified CHOP versus THP-COP versus THP-COPE Regimens in Elderly Patients with Non-Hodgkin’s Lymphoma

  2005cites this paper
• European experiences on aggressive non-Hodgkin's lymphoma in elderly patients.

  2004cites this paper
• Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi.

  2004cites this paper
• Treatment of Non-Hodgkin's Lymphoma in the Elderly. The Italian Studies

  2002cites this paper
• The role of mitoxantrone in non-Hodgkin's lymphoma.

  2002cites this paper
• Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO.

  2001cites this paper
• Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL).

  1999cites this paper